Why CVS Is Giving Plans A New Tool To Target High Launch Prices

Dr. Robert Dubois of the National Pharmaceutical Council (NPC) has expressed his concerns about CVS Health’s new service offering that allows self-funded plan sponsors (overwhelmingly employers) to exclude from coverage medications that have launch prices of greater than $100,000 per quality-adjusted life-year (QALY). He notes that this approach is “too much, too soon.” We appreciate the opportunity to respond.

Continue reading on Health Affairs.